Cancer MoonShot 2020 has announced the formation of the Pediatrics Consortium focused on bringing the promise of combined immunotherapy as the next-generation standard of cancer care to children diagnosed with the disease. With leadership at Phoenix Children’s Hospital helping to initiate this consortium, all founding partners will seek to apply the most comprehensive cancer molecular diagnostic testing available—integrating whole genomic and proteomic analysis—and leverage proven and promising combination immunotherapies and clinical trials through the QUILT (QUantitative Integrative Lifelong Trial) Program within the Cancer MoonShot 2020 mission. Real-time data-sharing, enabled by the infrastructure provided by Cancer MoonShot 2020, will accelerate clinical learning and insight to all members participating in the consortium.
Founding Members and Member Institutions
For more information on the Pediatrics Consortium, and Cancer MoonShot 2020, visit www.cancermoonshot2020.org. ■